[Reduction of the Nordin index after therapy with oral alendronate in patients with postmenopausal osteoporosis].

The authors observe a significant reduction in value of the Nordin's Index (a sensible test for the screening of the "fast-losers" patients) in 10 women with post-menopausal osteoporosis after therapy with alendronate 5 mg daily per os for six months. The authors propound the measurement of the Nordin's Index in order to assess the alendronate's therapy per os in the post-menopausal osteoporosis.